Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients
Noninvasive biomarkers with diagnostic value and prognostic applications have long been desired to replace muscle biopsy for Duchenne muscular dystrophy (DMD) patients. Growing evidence indicates that circulating microRNAs are biomarkers to assess pathophysiological status. Here, we show that the se...
Main Authors: | Xihua Li, Yuying Li, Lei Zhao, Duo Zhang, Xuan Yao, Huihui Zhang, Yu-cheng Wang, Xin-yi Wang, Hongfeng Xia, Jun Yan, Hao Ying |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253116303171 |
Similar Items
-
Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al. -
Strengthen the research of Duchenne muscular dystrophy in China
by: Cheng ZHANG
Published: (2015-06-01) -
Natural history of Duchenne muscular dystrophy
by: Qing KE, et al.
Published: (2015-05-01) -
Rehabilitation therapy of Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2012-06-01) -
Serum Creatinine Distinguishes Duchenne Muscular Dystrophy from Becker Muscular Dystrophy in Patients Aged ≤3 Years: A Retrospective Study
by: Liang Wang, et al.
Published: (2017-05-01)